Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.

Daugherty SE, Platz EA, Shugart YY, Fallin MD, Isaacs WB, Chatterjee N, Welch R, Huang WY, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1536-42.

2.

Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.

Daugherty SE, Shugart YY, Platz EA, Fallin MD, Isaacs WB, Pfeiffer RM, Welch R, Huang WY, Reding D, Hayes RB.

Prostate. 2007 Oct 1;67(14):1487-97.

PMID:
17680641
3.

Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.

Zheng SL, Chang BL, Faith DA, Johnson JR, Isaacs SD, Hawkins GA, Turner A, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB, Xu J.

Cancer Res. 2002 Nov 15;62(22):6485-8.

4.

Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.

FitzGerald LM, Thomson R, Polanowski A, Patterson B, McKay JD, Stankovich J, Dickinson JL.

Prostate. 2008 Sep 15;68(13):1373-9. doi: 10.1002/pros.20798.

PMID:
18537123
5.

Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.

Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, Chanock SJ, Foster CB.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54. doi: 10.1158/1055-9965.EPI-07-2947.

6.

Significant association of alpha-methylacyl-CoA racemase gene polymorphisms with susceptibility to prostate cancer: a meta-analysis.

Chen N, Wang JR, Huang L, Yang Y, Jiang YM, Guo XJ, He YZ, Zhou YH.

Asian Pac J Cancer Prev. 2015;16(5):1857-63.

7.

PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).

Slattery ML, Curtin K, Wolff R, Ma KN, Sweeney C, Murtaugh M, Potter JD, Levin TR, Samowitz W.

Cancer Causes Control. 2006 Apr;17(3):239-49.

PMID:
16489531
8.

A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma.

Jiang Z, Fanger GR, Banner BF, Woda BA, Algate P, Dresser K, Xu J, Reed SG, Rock KL, Chu PG.

Cancer Detect Prev. 2003;27(6):422-6.

PMID:
14642549
9.

Genetic variations of α -methylacyl-CoA racemase are associated with sporadic prostate cancer risk in ethnically homogenous Koreans.

Lee SJ, Joung JY, Yoon H, Kim JE, Park WS, Seo HK, Chung J, Hwang JA, Hong SH, Nam S, Park S, Kim J, Lee KH, Lee YS.

Biomed Res Int. 2013;2013:394285. doi: 10.1155/2013/394285. Epub 2013 Dec 7.

10.

Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.

Levin AM, Zuhlke KA, Ray AM, Cooney KA, Douglas JA.

Prostate. 2007 Oct 1;67(14):1507-13.

11.

AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.

Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, Stanford JL.

Prostate. 2011 Apr;71(5):498-506. doi: 10.1002/pros.21267. Epub 2010 Oct 13.

12.

AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.

Lakis S, Papamitsou T, Panagiotopoulou C, Kotakidou R, Kotoula V.

World J Gastroenterol. 2010 May 28;16(20):2476-83.

13.

Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.

Ueda N, Maehara Y, Tajima O, Tabata S, Wakabayashi K, Kono S.

Cancer Sci. 2008 Mar;99(3):576-81. doi: 10.1111/j.1349-7006.2007.00711.x. Epub 2007 Dec 19.

14.

Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.

Kang MY, Lee BB, Ji YI, Jung EH, Chun HK, Song SY, Park SE, Park J, Kim DH.

Cancer. 2008 Apr 15;112(8):1699-707. doi: 10.1002/cncr.23335.

15.

Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.

Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):306-11.

16.

Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk.

Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS, Velie EM, Brody LC.

Eur J Cancer. 2010 Sep;46(13):2457-66. doi: 10.1016/j.ejca.2010.04.020. Epub 2010 May 24.

17.

Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.

Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB.

Carcinogenesis. 2007 Sep;28(9):1965-70. Epub 2007 Jul 5.

PMID:
17615257
18.

Inflammation-related gene polymorphisms and colorectal adenoma.

Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1126-31.

19.

GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.

Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, Welch B, Pinsky P, Weissfeld J, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1823-7.

20.

Supplemental Content

Support Center